Adult-onset Still's disease pathophysiology: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
Line 10: Line 10:


=== Putative triggers ===
=== Putative triggers ===
Although the pathogenesis of adult-onset Still's disease is largerly idiopathic. Triggers of ASOD lead to activation of toll-like receptors (TLR) and activation of immune system. The following triggers may be implicated as factors responsible for generating key pathological processes occurring in adult-onset Still's disease (ASOD):<ref name="pmid11247732">{{cite journal |vauthors=Perez C, Artola V |title=Adult Still's disease associated with Mycoplasma pneumoniae infection |journal=Clin. Infect. Dis. |volume=32 |issue=6 |pages=E105–6 |date=March 2001 |pmid=11247732 |doi=10.1086/319342 |url=}}</ref><ref name="pmid21918897">{{cite journal |vauthors=Dua J, Nandagudi A, Sutcliffe N |title=Mycoplasma pneumoniae infection associated with urticarial vasculitis mimicking adult-onset Still's disease |journal=Rheumatol. Int. |volume=32 |issue=12 |pages=4053–6 |date=December 2012 |pmid=21918897 |doi=10.1007/s00296-011-2107-4 |url=}}</ref><ref name="pmid10885978">{{cite journal |vauthors=Escudero FJ, Len O, Falcó V, de Sevilla TF, Sellas A |title=Rubella infection in adult onset Still's disease |journal=Ann. Rheum. Dis. |volume=59 |issue=6 |pages=493 |date=June 2000 |pmid=10885978 |pmc=1753159 |doi= |url=}}</ref><ref name="pmid16949136">{{cite journal |vauthors=Efthimiou P, Georgy S |title=Pathogenesis and management of adult-onset Still's disease |journal=Semin. Arthritis Rheum. |volume=36 |issue=3 |pages=144–52 |date=December 2006 |pmid=16949136 |doi=10.1016/j.semarthrit.2006.07.001 |url=}}</ref><ref name="pmid3178317">{{cite journal |vauthors=Wouters JM, van der Veen J, van de Putte LB, de Rooij DJ |title=Adult onset Still's disease and viral infections |journal=Ann. Rheum. Dis. |volume=47 |issue=9 |pages=764–7 |date=September 1988 |pmid=3178317 |pmc=1003594 |doi= |url=}}</ref><ref name="pmid48775">{{cite journal |vauthors=Ogra PL, Chiba Y, Ogra SS, Dzierba JL, Herd JK |title=Rubella-virus infection in juvenile rheumatoid arthritis |journal=Lancet |volume=1 |issue=7917 |pages=1157–61 |date=May 1975 |pmid=48775 |doi= |url=}}</ref><ref name="pmid1081377">{{cite journal |vauthors=Linnemann CC, Levinson JE, Buncher CR, Schiff GM |title=Rubella antibody levels in juvenile rheumatoid arthritis |journal=Ann. Rheum. Dis. |volume=34 |issue=4 |pages=354–8 |date=August 1975 |pmid=1081377 |pmc=1006427 |doi= |url=}}</ref><ref name="pmid737022">{{cite journal |vauthors=Blotzer JW, Myers AR |title=Echovirus-associated polyarthritis. Report of a case with synovial fluid and synovial histologic characterization |journal=Arthritis Rheum. |volume=21 |issue=8 |pages=978–81 |date=1978 |pmid=737022 |doi= |url=}}</ref>
Although the pathogenesis of adult-onset Still's disease is largerly idiopathic. Triggers of AOSD lead to activation of toll-like receptors (TLR) and activation of immune system. The following triggers may be implicated as factors responsible for generating key pathological processes occurring in adult-onset Still's disease (AOSD):<ref name="pmid11247732">{{cite journal |vauthors=Perez C, Artola V |title=Adult Still's disease associated with Mycoplasma pneumoniae infection |journal=Clin. Infect. Dis. |volume=32 |issue=6 |pages=E105–6 |date=March 2001 |pmid=11247732 |doi=10.1086/319342 |url=}}</ref><ref name="pmid21918897">{{cite journal |vauthors=Dua J, Nandagudi A, Sutcliffe N |title=Mycoplasma pneumoniae infection associated with urticarial vasculitis mimicking adult-onset Still's disease |journal=Rheumatol. Int. |volume=32 |issue=12 |pages=4053–6 |date=December 2012 |pmid=21918897 |doi=10.1007/s00296-011-2107-4 |url=}}</ref><ref name="pmid10885978">{{cite journal |vauthors=Escudero FJ, Len O, Falcó V, de Sevilla TF, Sellas A |title=Rubella infection in adult onset Still's disease |journal=Ann. Rheum. Dis. |volume=59 |issue=6 |pages=493 |date=June 2000 |pmid=10885978 |pmc=1753159 |doi= |url=}}</ref><ref name="pmid16949136">{{cite journal |vauthors=Efthimiou P, Georgy S |title=Pathogenesis and management of adult-onset Still's disease |journal=Semin. Arthritis Rheum. |volume=36 |issue=3 |pages=144–52 |date=December 2006 |pmid=16949136 |doi=10.1016/j.semarthrit.2006.07.001 |url=}}</ref><ref name="pmid3178317">{{cite journal |vauthors=Wouters JM, van der Veen J, van de Putte LB, de Rooij DJ |title=Adult onset Still's disease and viral infections |journal=Ann. Rheum. Dis. |volume=47 |issue=9 |pages=764–7 |date=September 1988 |pmid=3178317 |pmc=1003594 |doi= |url=}}</ref><ref name="pmid48775">{{cite journal |vauthors=Ogra PL, Chiba Y, Ogra SS, Dzierba JL, Herd JK |title=Rubella-virus infection in juvenile rheumatoid arthritis |journal=Lancet |volume=1 |issue=7917 |pages=1157–61 |date=May 1975 |pmid=48775 |doi= |url=}}</ref><ref name="pmid1081377">{{cite journal |vauthors=Linnemann CC, Levinson JE, Buncher CR, Schiff GM |title=Rubella antibody levels in juvenile rheumatoid arthritis |journal=Ann. Rheum. Dis. |volume=34 |issue=4 |pages=354–8 |date=August 1975 |pmid=1081377 |pmc=1006427 |doi= |url=}}</ref><ref name="pmid737022">{{cite journal |vauthors=Blotzer JW, Myers AR |title=Echovirus-associated polyarthritis. Report of a case with synovial fluid and synovial histologic characterization |journal=Arthritis Rheum. |volume=21 |issue=8 |pages=978–81 |date=1978 |pmid=737022 |doi= |url=}}</ref>


'''Pathogen-associated molecular patterns (PAMPs)'''
'''Pathogen-associated molecular patterns (PAMPs)'''
Line 33: Line 33:


'''Changes in the innate immunity'''
'''Changes in the innate immunity'''
* Natural killer cells have been found to be decreased in patients with ASOD. The mechanism underlying dysfunctional NK cells is a defect in IL-18 receptor β phosphorylation.<ref name="de JagerVastert2009">{{cite journal|last1=de Jager|first1=Wilco|last2=Vastert|first2=Sebastiaan J.|last3=Beekman|first3=Jeffrey M.|last4=Wulffraat|first4=Nico M.|last5=Kuis|first5=Wietse|last6=Coffer|first6=Paul J.|last7=Prakken|first7=Berent J.|title=Defective phosphorylation of interleukin-18 receptor β causes impaired natural killer cell function in systemic-onset juvenile idiopathic arthritis|journal=Arthritis & Rheumatism|volume=60|issue=9|year=2009|pages=2782–2793|issn=00043591|doi=10.1002/art.24750}}</ref>
* Natural killer cells have been found to be decreased in patients with AOSD. The mechanism underlying dysfunctional NK cells is a defect in IL-18 receptor β phosphorylation.<ref name="de JagerVastert2009">{{cite journal|last1=de Jager|first1=Wilco|last2=Vastert|first2=Sebastiaan J.|last3=Beekman|first3=Jeffrey M.|last4=Wulffraat|first4=Nico M.|last5=Kuis|first5=Wietse|last6=Coffer|first6=Paul J.|last7=Prakken|first7=Berent J.|title=Defective phosphorylation of interleukin-18 receptor β causes impaired natural killer cell function in systemic-onset juvenile idiopathic arthritis|journal=Arthritis & Rheumatism|volume=60|issue=9|year=2009|pages=2782–2793|issn=00043591|doi=10.1002/art.24750}}</ref>
* Neutrophil and macrophage activation lie at the heart of pathogenesis of ASOD due to the effects of the proinflammatory interleukin-18 (IL-18) signalling.
* Neutrophil and macrophage activation lie at the heart of pathogenesis of AOSD due to the effects of the proinflammatory interleukin-18 (IL-18) signalling.
* CD64, a marker of neutrophil activation has been found to be upregulated in active ASOD.<ref name="pmid22420333">{{cite journal |vauthors=Komiya A, Matsui T, Nogi S, Iwata K, Futami H, Takaoka H, Arinuma Y, Hashimoto A, Shimada K, Ikenaka T, Nakayama H, Furukawa H, Tohma S |title=Neutrophil CD64 is upregulated in patients with active adult-onset Still's disease |journal=Scand. J. Rheumatol. |volume=41 |issue=2 |pages=156–8 |date=March 2012 |pmid=22420333 |doi=10.3109/03009742.2011.644325 |url=}}</ref>
* CD64, a marker of neutrophil activation has been found to be upregulated in active AOSD.<ref name="pmid22420333">{{cite journal |vauthors=Komiya A, Matsui T, Nogi S, Iwata K, Futami H, Takaoka H, Arinuma Y, Hashimoto A, Shimada K, Ikenaka T, Nakayama H, Furukawa H, Tohma S |title=Neutrophil CD64 is upregulated in patients with active adult-onset Still's disease |journal=Scand. J. Rheumatol. |volume=41 |issue=2 |pages=156–8 |date=March 2012 |pmid=22420333 |doi=10.3109/03009742.2011.644325 |url=}}</ref>
* Macrophage colony stimulating factor (MCSF), intercellular adhesion molecule-1 (ICAM-1) and calprotectin are elevated and act as markers of active disease.<ref name="pmid15934126">{{cite journal |vauthors=Chen DY, Lan JL, Lin FJ, Hsieh TY |title=Association of intercellular adhesion molecule-1 with clinical manifestations and interleukin-18 in patients with active, untreated adult-onset Still's disease |journal=Arthritis Rheum. |volume=53 |issue=3 |pages=320–7 |date=June 2005 |pmid=15934126 |doi=10.1002/art.21164 |url=}}</ref><ref name="pmid10371293">{{cite journal |vauthors=Matsui K, Tsuchida T, Hiroishi K, Tominaga K, Hayashi N, Hada T, Higashino K |title=High serum level of macrophage-colony stimulating factor (M-CSF) in adult-onset Still's disease |journal=Rheumatology (Oxford) |volume=38 |issue=5 |pages=477–8 |date=May 1999 |pmid=10371293 |doi= |url=}}</ref>
* Macrophage colony stimulating factor (MCSF), intercellular adhesion molecule-1 (ICAM-1) and calprotectin are elevated and act as markers of active disease.<ref name="pmid15934126">{{cite journal |vauthors=Chen DY, Lan JL, Lin FJ, Hsieh TY |title=Association of intercellular adhesion molecule-1 with clinical manifestations and interleukin-18 in patients with active, untreated adult-onset Still's disease |journal=Arthritis Rheum. |volume=53 |issue=3 |pages=320–7 |date=June 2005 |pmid=15934126 |doi=10.1002/art.21164 |url=}}</ref><ref name="pmid10371293">{{cite journal |vauthors=Matsui K, Tsuchida T, Hiroishi K, Tominaga K, Hayashi N, Hada T, Higashino K |title=High serum level of macrophage-colony stimulating factor (M-CSF) in adult-onset Still's disease |journal=Rheumatology (Oxford) |volume=38 |issue=5 |pages=477–8 |date=May 1999 |pmid=10371293 |doi= |url=}}</ref>
'''Changes in the adaptive immunity'''
'''Changes in the adaptive immunity'''
* T cell activation has also been shown to play role in the pathogenesis of ASOD with Th1 (cytotoxic) subset prevailing over Th2 CD4+ T cells.
* T cell activation has also been shown to play role in the pathogenesis of AOSD with Th1 (cytotoxic) subset prevailing over Th2 CD4+ T cells.
* Increased number of Th17 cells  derived from the differentiation of naieve CD4+ T cells due to to activation by interleukin-1 beta, transforming growth factor-beta and interleukin- 6 is also seen in active ASOD. <ref name="pmid20837500">{{cite journal |vauthors=Chen DY, Chen YM, Lan JL, Lin CC, Chen HH, Hsieh CW |title=Potential role of Th17 cells in the pathogenesis of adult-onset Still's disease |journal=Rheumatology (Oxford) |volume=49 |issue=12 |pages=2305–12 |date=December 2010 |pmid=20837500 |doi=10.1093/rheumatology/keq284 |url=}}</ref><ref name="pmid16200068">{{cite journal |vauthors=Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, Wang Y, Hood L, Zhu Z, Tian Q, Dong C |title=A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 |journal=Nat. Immunol. |volume=6 |issue=11 |pages=1133–41 |date=November 2005 |pmid=16200068 |pmc=1618871 |doi=10.1038/ni1261 |url=}}</ref>
* Increased number of Th17 cells  derived from the differentiation of naieve CD4+ T cells due to to activation by interleukin-1 beta, transforming growth factor-beta and interleukin- 6 is also seen in active AOSD. <ref name="pmid20837500">{{cite journal |vauthors=Chen DY, Chen YM, Lan JL, Lin CC, Chen HH, Hsieh CW |title=Potential role of Th17 cells in the pathogenesis of adult-onset Still's disease |journal=Rheumatology (Oxford) |volume=49 |issue=12 |pages=2305–12 |date=December 2010 |pmid=20837500 |doi=10.1093/rheumatology/keq284 |url=}}</ref><ref name="pmid16200068">{{cite journal |vauthors=Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, Wang Y, Hood L, Zhu Z, Tian Q, Dong C |title=A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 |journal=Nat. Immunol. |volume=6 |issue=11 |pages=1133–41 |date=November 2005 |pmid=16200068 |pmc=1618871 |doi=10.1038/ni1261 |url=}}</ref>


=== Role of interleukin-1 beta (IL-1), interleukin-6 (IL-6), interferon-alpha (IFN-alpha) and tumor necrosis factor (TNF-alpha) ===
=== Role of interleukin-1 beta (IL-1), interleukin-6 (IL-6), interferon-alpha (IFN-alpha) and tumor necrosis factor (TNF-alpha) ===
Interleukin-i beta plays a key role in producing major characteristic features of adult-onset Still's disease. PAMPs and DAMPs lead to stimulation of protein complex nucleotide-binding oligomerization-domain-(NOD-) like receptor family, pyrin domain containing 3 (NLRP3) inflammasome (expressed in myeloid cells). The consequence of all these trigger-stimulated NOD and NLRP increasing interactions is an increased production of interleukin-1 beta.<ref name="pmid15851489">{{cite journal |vauthors=Pascual V, Allantaz F, Arce E, Punaro M, Banchereau J |title=Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade |journal=J. Exp. Med. |volume=201 |issue=9 |pages=1479–86 |date=May 2005 |pmid=15851489 |pmc=2213182 |doi=10.1084/jem.20050473 |url=}}</ref>The following processes are affected by an increased production of this key interleukin of ASOD:
Interleukin-i beta plays a key role in producing major characteristic features of adult-onset Still's disease. PAMPs and DAMPs lead to stimulation of protein complex nucleotide-binding oligomerization-domain-(NOD-) like receptor family, pyrin domain containing 3 (NLRP3) inflammasome (expressed in myeloid cells). The consequence of all these trigger-stimulated NOD and NLRP increasing interactions is an increased production of interleukin-1 beta.<ref name="pmid15851489">{{cite journal |vauthors=Pascual V, Allantaz F, Arce E, Punaro M, Banchereau J |title=Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade |journal=J. Exp. Med. |volume=201 |issue=9 |pages=1479–86 |date=May 2005 |pmid=15851489 |pmc=2213182 |doi=10.1084/jem.20050473 |url=}}</ref>The following processes are affected by an increased production of this key interleukin of AOSD:


'''(a) Hypothalamic-pituitary axis influence'''
'''(a) Hypothalamic-pituitary axis influence'''
Line 57: Line 57:
'''(b) Liver synthesis and secretion of acute phase proteins'''
'''(b) Liver synthesis and secretion of acute phase proteins'''


Both interleukin-1 beta, interleukin-6 and interferon-alpha (IFN-alpha) lead to increased production of acute phase reactants by the liver due to inflammatory and oxidative stress occurring during active ASOD. The following acute phase reactant proteins are elevated in ASOD as a result of increased liver production:<ref name="pmid12184429">{{cite journal |vauthors=Fautrel B |title=Ferritin levels in adult Still's disease: any sugar? |journal=Joint Bone Spine |volume=69 |issue=4 |pages=355–7 |date=June 2002 |pmid=12184429 |doi= |url=}}</ref><ref name="pmid118864362">{{cite journal |vauthors=Stam TC, Swaak AJ, Kruit WH, Eggermont AM |title=Regulation of ferritin: a specific role for interferon-alpha (IFN-alpha)? The acute phase response in patients treated with IFN-alpha-2b |journal=Eur. J. Clin. Invest. |volume=32 Suppl 1 |issue= |pages=79–83 |date=March 2002 |pmid=11886436 |doi= |url=}}</ref>
Both interleukin-1 beta, interleukin-6 and interferon-alpha (IFN-alpha) lead to increased production of acute phase reactants by the liver due to inflammatory and oxidative stress occurring during active AOSD. The following acute phase reactant proteins are elevated in AOSD as a result of increased liver production:<ref name="pmid12184429">{{cite journal |vauthors=Fautrel B |title=Ferritin levels in adult Still's disease: any sugar? |journal=Joint Bone Spine |volume=69 |issue=4 |pages=355–7 |date=June 2002 |pmid=12184429 |doi= |url=}}</ref><ref name="pmid118864362">{{cite journal |vauthors=Stam TC, Swaak AJ, Kruit WH, Eggermont AM |title=Regulation of ferritin: a specific role for interferon-alpha (IFN-alpha)? The acute phase response in patients treated with IFN-alpha-2b |journal=Eur. J. Clin. Invest. |volume=32 Suppl 1 |issue= |pages=79–83 |date=March 2002 |pmid=11886436 |doi= |url=}}</ref>
* C-reactive protein (CRP)
* C-reactive protein (CRP)
* Ferritin  
* Ferritin  
Line 64: Line 64:
'''(c) Osteoclasts activation and matrix metalloproteinases (MMPs) synthesis'''
'''(c) Osteoclasts activation and matrix metalloproteinases (MMPs) synthesis'''


Interleukin-1 and TNF-alpha have been shown to inhibit chondrogenesis leading to decreased repair process of bone and cartilage in ASOD.<ref name="WehlingPalmer2009">{{cite journal|last1=Wehling|first1=N.|last2=Palmer|first2=G. D.|last3=Pilapil|first3=C.|last4=Liu|first4=F.|last5=Wells|first5=J. W.|last6=Müller|first6=P. E.|last7=Evans|first7=C. H.|last8=Porter|first8=R. M.|title=Interleukin-1β and tumor necrosis factor α inhibit chondrogenesis by human mesenchymal stem cells through NF-κB-dependent pathways|journal=Arthritis & Rheumatism|volume=60|issue=3|year=2009|pages=801–812|issn=00043591|doi=10.1002/art.24352}}</ref>
Interleukin-1 and TNF-alpha have been shown to inhibit chondrogenesis leading to decreased repair process of bone and cartilage in AOSD.<ref name="WehlingPalmer2009">{{cite journal|last1=Wehling|first1=N.|last2=Palmer|first2=G. D.|last3=Pilapil|first3=C.|last4=Liu|first4=F.|last5=Wells|first5=J. W.|last6=Müller|first6=P. E.|last7=Evans|first7=C. H.|last8=Porter|first8=R. M.|title=Interleukin-1β and tumor necrosis factor α inhibit chondrogenesis by human mesenchymal stem cells through NF-κB-dependent pathways|journal=Arthritis & Rheumatism|volume=60|issue=3|year=2009|pages=801–812|issn=00043591|doi=10.1002/art.24352}}</ref>


'''(d) Innate immune system cells activation'''
'''(d) Innate immune system cells activation'''
Line 72: Line 72:
'''(e) Increased gene transcription of proinflammatory molecules'''
'''(e) Increased gene transcription of proinflammatory molecules'''


The following proinflammatory factors are produced in an increased concentration in ASOD:
The following proinflammatory factors are produced in an increased concentration in AOSD:
* Inducible nitric oxide synthase (iNOS)<ref name="pmid10952018">{{cite journal |vauthors=Zamora R, Vodovotz Y, Billiar TR |title=Inducible nitric oxide synthase and inflammatory diseases |journal=Mol. Med. |volume=6 |issue=5 |pages=347–73 |date=May 2000 |pmid=10952018 |pmc=1949959 |doi= |url=}}</ref>
* Inducible nitric oxide synthase (iNOS)<ref name="pmid10952018">{{cite journal |vauthors=Zamora R, Vodovotz Y, Billiar TR |title=Inducible nitric oxide synthase and inflammatory diseases |journal=Mol. Med. |volume=6 |issue=5 |pages=347–73 |date=May 2000 |pmid=10952018 |pmc=1949959 |doi= |url=}}</ref>
* Innter leukin 1, 6 and TNF-alpha induced cyclo-oxygenase 2 (COX2)<ref name="pmid10704080">{{cite journal |vauthors=García JE, López AM, de Cabo MR, Rodríguez FM, Losada JP, Sarmiento RG, López AJ, Arellano JL |title=Cyclosporin A decreases human macrophage interleukin-6 synthesis at post-transcriptional level |journal=Mediators Inflamm. |volume=8 |issue=4-5 |pages=253–9 |date=1999 |pmid=10704080 |pmc=1781800 |doi=10.1080/09629359990423 |url=}}</ref>
* Innter leukin 1, 6 and TNF-alpha induced cyclo-oxygenase 2 (COX2)<ref name="pmid10704080">{{cite journal |vauthors=García JE, López AM, de Cabo MR, Rodríguez FM, Losada JP, Sarmiento RG, López AJ, Arellano JL |title=Cyclosporin A decreases human macrophage interleukin-6 synthesis at post-transcriptional level |journal=Mediators Inflamm. |volume=8 |issue=4-5 |pages=253–9 |date=1999 |pmid=10704080 |pmc=1781800 |doi=10.1080/09629359990423 |url=}}</ref>
Line 80: Line 80:


=== Role of interleukin-18 ===
=== Role of interleukin-18 ===
It is produced by macrophages and monocytes as a consequence of bacterial and viral infections (which are thought to be triggers of ASOD).<ref name="pmid12355506">{{cite journal |vauthors=Maeno N, Takei S, Nomura Y, Imanaka H, Hokonohara M, Miyata K |title=Highly elevated serum levels of interleukin-18 in systemic juvenile idiopathic arthritis but not in other juvenile idiopathic arthritis subtypes or in Kawasaki disease: comment on the article by Kawashima et al |journal=Arthritis Rheum. |volume=46 |issue=9 |pages=2539–41; author reply 2541–2 |date=September 2002 |pmid=12355506 |doi=10.1002/art.10389 |url=}}</ref> A defective phosphorylation of IL-18 receptor is though to give rise to this dysfunction.<ref name="pmid19714583">{{cite journal |vauthors=de Jager W, Vastert SJ, Beekman JM, Wulffraat NM, Kuis W, Coffer PJ, Prakken BJ |title=Defective phosphorylation of interleukin-18 receptor beta causes impaired natural killer cell function in systemic-onset juvenile idiopathic arthritis |journal=Arthritis Rheum. |volume=60 |issue=9 |pages=2782–93 |date=September 2009 |pmid=19714583 |doi=10.1002/art.24750 |url=}}</ref>
It is produced by macrophages and monocytes as a consequence of bacterial and viral infections (which are thought to be triggers of AOSD).<ref name="pmid12355506">{{cite journal |vauthors=Maeno N, Takei S, Nomura Y, Imanaka H, Hokonohara M, Miyata K |title=Highly elevated serum levels of interleukin-18 in systemic juvenile idiopathic arthritis but not in other juvenile idiopathic arthritis subtypes or in Kawasaki disease: comment on the article by Kawashima et al |journal=Arthritis Rheum. |volume=46 |issue=9 |pages=2539–41; author reply 2541–2 |date=September 2002 |pmid=12355506 |doi=10.1002/art.10389 |url=}}</ref> A defective phosphorylation of IL-18 receptor is though to give rise to this dysfunction.<ref name="pmid19714583">{{cite journal |vauthors=de Jager W, Vastert SJ, Beekman JM, Wulffraat NM, Kuis W, Coffer PJ, Prakken BJ |title=Defective phosphorylation of interleukin-18 receptor beta causes impaired natural killer cell function in systemic-onset juvenile idiopathic arthritis |journal=Arthritis Rheum. |volume=60 |issue=9 |pages=2782–93 |date=September 2009 |pmid=19714583 |doi=10.1002/art.24750 |url=}}</ref>


=== Role of interleukin-17 ===
=== Role of interleukin-17 ===
Line 86: Line 86:


=== Role of interferon gamma ===
=== Role of interferon gamma ===
Imblanced production of interferon-gamma is thought to be associated with ASOD.<ref name="pmid24470448">{{cite journal |vauthors=Canna SW |title=Editorial: interferon-γ: friend or foe in systemic juvenile idiopathic arthritis and adult-onset Still's Disease? |journal=Arthritis Rheumatol |volume=66 |issue=5 |pages=1072–6 |date=May 2014 |pmid=24470448 |pmc=4181835 |doi=10.1002/art.38362 |url=}}</ref>  Levels of the IFN-γ-induced chemokines, CXCL9, CXCL10 and CXCL11 are increased during active phase of ASOD.<ref name="pmid28436448">{{cite journal |vauthors=Han JH, Suh CH, Jung JY, Ahn MH, Han MH, Kwon JE, Yim H, Kim HA |title=Elevated circulating levels of the interferon-γ-induced chemokines are associated with disease activity and cutaneous manifestations in adult-onset Still's disease |journal=Sci Rep |volume=7 |issue= |pages=46652 |date=April 2017 |pmid=28436448 |pmc=5402387 |doi=10.1038/srep46652 |url=}}</ref>
Imblanced production of interferon-gamma is thought to be associated with AOSD.<ref name="pmid24470448">{{cite journal |vauthors=Canna SW |title=Editorial: interferon-γ: friend or foe in systemic juvenile idiopathic arthritis and adult-onset Still's Disease? |journal=Arthritis Rheumatol |volume=66 |issue=5 |pages=1072–6 |date=May 2014 |pmid=24470448 |pmc=4181835 |doi=10.1002/art.38362 |url=}}</ref>  Levels of the IFN-γ-induced chemokines, CXCL9, CXCL10 and CXCL11 are increased during active phase of AOSD.<ref name="pmid28436448">{{cite journal |vauthors=Han JH, Suh CH, Jung JY, Ahn MH, Han MH, Kwon JE, Yim H, Kim HA |title=Elevated circulating levels of the interferon-γ-induced chemokines are associated with disease activity and cutaneous manifestations in adult-onset Still's disease |journal=Sci Rep |volume=7 |issue= |pages=46652 |date=April 2017 |pmid=28436448 |pmc=5402387 |doi=10.1038/srep46652 |url=}}</ref>


=== Reactive hemophagocytic lymphohistiocytosis ===
=== Reactive hemophagocytic lymphohistiocytosis ===

Revision as of 18:08, 8 April 2018


Template:Adult-onset Still's disease Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Pathophysiology

Adult-onset Still's disease is an automminue inflammatory arthritis that typically affects adolescents and adults ranging from age 16-40 years. Major etiological mechanisms behind cause a dysfunction of the innate and cellular immunity (limited) leading to activation of effector cells of the disease.

Putative triggers

Although the pathogenesis of adult-onset Still's disease is largerly idiopathic. Triggers of AOSD lead to activation of toll-like receptors (TLR) and activation of immune system. The following triggers may be implicated as factors responsible for generating key pathological processes occurring in adult-onset Still's disease (AOSD):[1][2][3][4][5][6][7][8]

Pathogen-associated molecular patterns (PAMPs)

  • Bacteria
    • Yersinia enterocolitica
    • Chlamydophila pneumoniae
    • Brucella abortus
    • Borrelia burgdorferi
  • Viruses
    • Rubella
    • Echovirus 7
    • Mumps
    • Cytomegalovirus (CMV)
  • Fungi

Danger-associated molecular patterns (DAMPs)

  • Chemicals
  • Toxins
  • Stress

Immune dysfunction

Both innate and adaptive immunity play roles in the pathological evolution of adult-onset Still's disease with the dysfunction occurring in the innate immunity predominating the picture. The following dysfunctions are involved:

Changes in the innate immunity

  • Natural killer cells have been found to be decreased in patients with AOSD. The mechanism underlying dysfunctional NK cells is a defect in IL-18 receptor β phosphorylation.[9]
  • Neutrophil and macrophage activation lie at the heart of pathogenesis of AOSD due to the effects of the proinflammatory interleukin-18 (IL-18) signalling.
  • CD64, a marker of neutrophil activation has been found to be upregulated in active AOSD.[10]
  • Macrophage colony stimulating factor (MCSF), intercellular adhesion molecule-1 (ICAM-1) and calprotectin are elevated and act as markers of active disease.[11][12]

Changes in the adaptive immunity

  • T cell activation has also been shown to play role in the pathogenesis of AOSD with Th1 (cytotoxic) subset prevailing over Th2 CD4+ T cells.
  • Increased number of Th17 cells derived from the differentiation of naieve CD4+ T cells due to to activation by interleukin-1 beta, transforming growth factor-beta and interleukin- 6 is also seen in active AOSD. [13][14]

Role of interleukin-1 beta (IL-1), interleukin-6 (IL-6), interferon-alpha (IFN-alpha) and tumor necrosis factor (TNF-alpha)

Interleukin-i beta plays a key role in producing major characteristic features of adult-onset Still's disease. PAMPs and DAMPs lead to stimulation of protein complex nucleotide-binding oligomerization-domain-(NOD-) like receptor family, pyrin domain containing 3 (NLRP3) inflammasome (expressed in myeloid cells). The consequence of all these trigger-stimulated NOD and NLRP increasing interactions is an increased production of interleukin-1 beta.[15]The following processes are affected by an increased production of this key interleukin of AOSD:

(a) Hypothalamic-pituitary axis influence

Activation of the hypothalmic-pitutary axis by interleukin-1 beta lead to the following changes:

Hormonal

  • An increased secretion of adenocorticotrophic hormone (ACTH) and anti-diuretic hormone (ADH).
  • A decreased secretion of growth hormone (GH) and somatostatin.[16]

Systemic

  • Disturbance of the thalmic temperature regulating centres leading to fever.[17]
  • Fatigue[18]
  • Anorexia[19] 

(b) Liver synthesis and secretion of acute phase proteins

Both interleukin-1 beta, interleukin-6 and interferon-alpha (IFN-alpha) lead to increased production of acute phase reactants by the liver due to inflammatory and oxidative stress occurring during active AOSD. The following acute phase reactant proteins are elevated in AOSD as a result of increased liver production:[20][21]

  • C-reactive protein (CRP)
  • Ferritin  
  • Serum amyloid protein (SAA)

(c) Osteoclasts activation and matrix metalloproteinases (MMPs) synthesis

Interleukin-1 and TNF-alpha have been shown to inhibit chondrogenesis leading to decreased repair process of bone and cartilage in AOSD.[22]

(d) Innate immune system cells activation

Effector cells of the innate immune system such as macrophages and neutrophils are activated mainly due to interleukin-1. The neutrophil to lymphocyte count ratio is increased due to elevated neutrophils.[23]

(e) Increased gene transcription of proinflammatory molecules

The following proinflammatory factors are produced in an increased concentration in AOSD:

  • Inducible nitric oxide synthase (iNOS)[24]
  • Innter leukin 1, 6 and TNF-alpha induced cyclo-oxygenase 2 (COX2)[25]
  • Phospholipase A2[26]
  • Intracellular adhesion molecules[27]
  • Colony-stimulating factors (CSF)[28]

Role of interleukin-18

It is produced by macrophages and monocytes as a consequence of bacterial and viral infections (which are thought to be triggers of AOSD).[29] A defective phosphorylation of IL-18 receptor is though to give rise to this dysfunction.[30]

Role of interleukin-17

Th17 cells lead to an increased production of interleukin-17. The stimulaton of Th17 cells is drived by interleukin-1, transforming growth factor beta (TGF-beta) and interleukin-6.[31][32]

Role of interferon gamma

Imblanced production of interferon-gamma is thought to be associated with AOSD.[33]  Levels of the IFN-γ-induced chemokines, CXCL9, CXCL10 and CXCL11 are increased during active phase of AOSD.[34]

 Reactive hemophagocytic lymphohistiocytosis 

Genetics

Associated Conditions

Gross Pathology

Microscopic Pathology

References

  1. ↑ Perez C, Artola V (March 2001). "Adult Still's disease associated with Mycoplasma pneumoniae infection". Clin. Infect. Dis. 32 (6): E105–6. doi:10.1086/319342. PMID 11247732.
  2. ↑ Dua J, Nandagudi A, Sutcliffe N (December 2012). "Mycoplasma pneumoniae infection associated with urticarial vasculitis mimicking adult-onset Still's disease". Rheumatol. Int. 32 (12): 4053–6. doi:10.1007/s00296-011-2107-4. PMID 21918897.
  3. ↑ Escudero FJ, Len O, Falcó V, de Sevilla TF, Sellas A (June 2000). "Rubella infection in adult onset Still's disease". Ann. Rheum. Dis. 59 (6): 493. PMC 1753159. PMID 10885978.
  4. ↑ Efthimiou P, Georgy S (December 2006). "Pathogenesis and management of adult-onset Still's disease". Semin. Arthritis Rheum. 36 (3): 144–52. doi:10.1016/j.semarthrit.2006.07.001. PMID 16949136.
  5. ↑ Wouters JM, van der Veen J, van de Putte LB, de Rooij DJ (September 1988). "Adult onset Still's disease and viral infections". Ann. Rheum. Dis. 47 (9): 764–7. PMC 1003594. PMID 3178317.
  6. ↑ Ogra PL, Chiba Y, Ogra SS, Dzierba JL, Herd JK (May 1975). "Rubella-virus infection in juvenile rheumatoid arthritis". Lancet. 1 (7917): 1157–61. PMID 48775.
  7. ↑ Linnemann CC, Levinson JE, Buncher CR, Schiff GM (August 1975). "Rubella antibody levels in juvenile rheumatoid arthritis". Ann. Rheum. Dis. 34 (4): 354–8. PMC 1006427. PMID 1081377.
  8. ↑ Blotzer JW, Myers AR (1978). "Echovirus-associated polyarthritis. Report of a case with synovial fluid and synovial histologic characterization". Arthritis Rheum. 21 (8): 978–81. PMID 737022.
  9. ↑ de Jager, Wilco; Vastert, Sebastiaan J.; Beekman, Jeffrey M.; Wulffraat, Nico M.; Kuis, Wietse; Coffer, Paul J.; Prakken, Berent J. (2009). "Defective phosphorylation of interleukin-18 receptor β causes impaired natural killer cell function in systemic-onset juvenile idiopathic arthritis". Arthritis & Rheumatism. 60 (9): 2782–2793. doi:10.1002/art.24750. ISSN 0004-3591.
  10. ↑ Komiya A, Matsui T, Nogi S, Iwata K, Futami H, Takaoka H, Arinuma Y, Hashimoto A, Shimada K, Ikenaka T, Nakayama H, Furukawa H, Tohma S (March 2012). "Neutrophil CD64 is upregulated in patients with active adult-onset Still's disease". Scand. J. Rheumatol. 41 (2): 156–8. doi:10.3109/03009742.2011.644325. PMID 22420333.
  11. ↑ Chen DY, Lan JL, Lin FJ, Hsieh TY (June 2005). "Association of intercellular adhesion molecule-1 with clinical manifestations and interleukin-18 in patients with active, untreated adult-onset Still's disease". Arthritis Rheum. 53 (3): 320–7. doi:10.1002/art.21164. PMID 15934126.
  12. ↑ Matsui K, Tsuchida T, Hiroishi K, Tominaga K, Hayashi N, Hada T, Higashino K (May 1999). "High serum level of macrophage-colony stimulating factor (M-CSF) in adult-onset Still's disease". Rheumatology (Oxford). 38 (5): 477–8. PMID 10371293.
  13. ↑ Chen DY, Chen YM, Lan JL, Lin CC, Chen HH, Hsieh CW (December 2010). "Potential role of Th17 cells in the pathogenesis of adult-onset Still's disease". Rheumatology (Oxford). 49 (12): 2305–12. doi:10.1093/rheumatology/keq284. PMID 20837500.
  14. ↑ Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, Wang Y, Hood L, Zhu Z, Tian Q, Dong C (November 2005). "A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17". Nat. Immunol. 6 (11): 1133–41. doi:10.1038/ni1261. PMC 1618871. PMID 16200068.
  15. ↑ Pascual V, Allantaz F, Arce E, Punaro M, Banchereau J (May 2005). "Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade". J. Exp. Med. 201 (9): 1479–86. doi:10.1084/jem.20050473. PMC 2213182. PMID 15851489.
  16. ↑ Ward DJ, Hartog M, Ansell BM (September 1966). "Corticosteroid-induced dwarfism in Still's disease treated with human growth hormone. Clinical and metabolic effects including hydroxyproline excretion in two cases". Ann. Rheum. Dis. 25 (5): 416–21. PMC 2453455. PMID 5915585.
  17. ↑ "onlinelibrary.wiley.com".
  18. ↑ Rossi-Semerano L, Koné-Paut I (2012). "Is Still's Disease an Autoinflammatory Syndrome?". Int J Inflam. 2012: 480373. doi:10.1155/2012/480373. PMC 3350968. PMID 22611516.
  19. ↑ Rossi-Semerano L, Koné-Paut I (2012). "Is Still's Disease an Autoinflammatory Syndrome?". Int J Inflam. 2012: 480373. doi:10.1155/2012/480373. PMC 3350968. PMID 22611516.
  20. ↑ Fautrel B (June 2002). "Ferritin levels in adult Still's disease: any sugar?". Joint Bone Spine. 69 (4): 355–7. PMID 12184429.
  21. ↑ Stam TC, Swaak AJ, Kruit WH, Eggermont AM (March 2002). "Regulation of ferritin: a specific role for interferon-alpha (IFN-alpha)? The acute phase response in patients treated with IFN-alpha-2b". Eur. J. Clin. Invest. 32 Suppl 1: 79–83. PMID 11886436.
  22. ↑ Wehling, N.; Palmer, G. D.; Pilapil, C.; Liu, F.; Wells, J. W.; Müller, P. E.; Evans, C. H.; Porter, R. M. (2009). "Interleukin-1β and tumor necrosis factor α inhibit chondrogenesis by human mesenchymal stem cells through NF-κB-dependent pathways". Arthritis & Rheumatism. 60 (3): 801–812. doi:10.1002/art.24352. ISSN 0004-3591.
  23. ↑ Seo JY, Suh CH, Jung JY, Kim AR, Yang JW, Kim HA (July 2017). "The neutrophil-to-lymphocyte ratio could be a good diagnostic marker and predictor of relapse in patients with adult-onset Still's disease: A STROBE-compliant retrospective observational analysis". Medicine (Baltimore). 96 (29): e7546. doi:10.1097/MD.0000000000007546. PMC 5521915. PMID 28723775.
  24. ↑ Zamora R, Vodovotz Y, Billiar TR (May 2000). "Inducible nitric oxide synthase and inflammatory diseases". Mol. Med. 6 (5): 347–73. PMC 1949959. PMID 10952018.
  25. ↑ García JE, López AM, de Cabo MR, Rodríguez FM, Losada JP, Sarmiento RG, López AJ, Arellano JL (1999). "Cyclosporin A decreases human macrophage interleukin-6 synthesis at post-transcriptional level". Mediators Inflamm. 8 (4–5): 253–9. doi:10.1080/09629359990423. PMC 1781800. PMID 10704080.
  26. ↑ Woese CR (July 1979). "A proposal concerning the origin of life on the planet earth". J. Mol. Evol. 13 (2): 95–101. PMID 480373.
  27. ↑ Chen DY, Lan JL, Lin FJ, Hsieh TY (June 2005). "Association of intercellular adhesion molecule-1 with clinical manifestations and interleukin-18 in patients with active, untreated adult-onset Still's disease". Arthritis Rheum. 53 (3): 320–7. doi:10.1002/art.21164. PMID 15934126.
  28. ↑ Takeshita A, Takeuchi T, Nakagawa A, Tsuda Y, Fukuda A, Nariyama K, Shibayama Y (May 2000). "Adult onset Still's disease with hemophagocytic syndrome and severe liver dysfunction". Hepatol. Res. 17 (2): 139–144. PMID 10707007.
  29. ↑ Maeno N, Takei S, Nomura Y, Imanaka H, Hokonohara M, Miyata K (September 2002). "Highly elevated serum levels of interleukin-18 in systemic juvenile idiopathic arthritis but not in other juvenile idiopathic arthritis subtypes or in Kawasaki disease: comment on the article by Kawashima et al". Arthritis Rheum. 46 (9): 2539–41, author reply 2541–2. doi:10.1002/art.10389. PMID 12355506.
  30. ↑ de Jager W, Vastert SJ, Beekman JM, Wulffraat NM, Kuis W, Coffer PJ, Prakken BJ (September 2009). "Defective phosphorylation of interleukin-18 receptor beta causes impaired natural killer cell function in systemic-onset juvenile idiopathic arthritis". Arthritis Rheum. 60 (9): 2782–93. doi:10.1002/art.24750. PMID 19714583.
  31. ↑ Chen DY, Lin CC, Chen YM, Lan JL, Hung WT, Chen HH, Lai KL, Hsieh CW (March 2013). "Involvement of TLR7 MyD88-dependent signaling pathway in the pathogenesis of adult-onset Still's disease". Arthritis Res. Ther. 15 (2): R39. doi:10.1186/ar4193. PMC 3672755. PMID 23497717.
  32. ↑ Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, Wang Y, Hood L, Zhu Z, Tian Q, Dong C (November 2005). "A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17". Nat. Immunol. 6 (11): 1133–41. doi:10.1038/ni1261. PMC 1618871. PMID 16200068.
  33. ↑ Canna SW (May 2014). "Editorial: interferon-γ: friend or foe in systemic juvenile idiopathic arthritis and adult-onset Still's Disease?". Arthritis Rheumatol. 66 (5): 1072–6. doi:10.1002/art.38362. PMC 4181835. PMID 24470448.
  34. ↑ Han JH, Suh CH, Jung JY, Ahn MH, Han MH, Kwon JE, Yim H, Kim HA (April 2017). "Elevated circulating levels of the interferon-γ-induced chemokines are associated with disease activity and cutaneous manifestations in adult-onset Still's disease". Sci Rep. 7: 46652. doi:10.1038/srep46652. PMC 5402387. PMID 28436448.

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Adult-onset_Still%27s_disease_pathophysiology&oldid=1460255"